Talmanco

Medicinal product

(Invented) name

Talmanco

Active substance (s)

Tadalafilis

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BE08, Tadalafil

Marketing authorisation holder

Viatris Limited, Airija

Date of authorisation

2017-01-09

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Tadalafilis	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
67442	81994	1081994	lizdinė plokštelė	N28		Receptinis	EU/1/16/1153/001	Netiekiama	-	-	No	-	-
67443	81995	1081995	dalomoji lizdinė plokštelė	N28x1		Receptinis	EU/1/16/1153/002	Netiekiama	-	-	No	-	-
67444	81996	1081996	lizdinė plokštelė	N56		Receptinis	EU/1/16/1153/003	Netiekiama	-	-	No	-	-
67445	81997	1081997	dalomoji lizdinė plokštelė	N56x1		Receptinis	EU/1/16/1153/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-01-09	Registruotas